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The clinical presentation of diabetic ketoacidosis in pregnancy (DKP) is similar to that observed in 
nonpregnant women, although reports suggest the presenting blood glucose level may not be as 
high. It is hypothesized that lower, maternal fasting glucose levels are a result of both the fetus and 
the placenta consuming glucose. We report the case of a 38-year-old woman gravida 2, para 0, 
abortion 1 with type 1 diabetes who had euglycemic diabetic ketoacidosis and review the literature 
on DKP, with a focus on diagnosis, treatment, and monitoring of the mother and fetus. [Clin Pract 
Cases Emerg Med.2020;4(1):X–X.]
INTRODUCTION
Diabetic ketoacidosis in pregnancy (DKP) is a 
serious complication that develops because of relative or 
absolute insulin deficiency and a simultaneous increase in 
counter-regulatory hormones.1 DKP is usually observed 
in patients with type 1 diabetes, but it can also occur in 
those with type 2 and gestational diabetes.2 It is likely to 
be precipitated by specific factors, such as hyperemesis 
gravidarum, starvation, infections, nonadherence to insulin 
therapy, and certain medications (e.g., steroids).2,3
Euglycemic DKP is a rare situation where the 
patient presents with diabetic ketoacidosis and normal or 
subnormal blood glucose levels. The putative mechanisms 
are a combination of glucose consumption by the 
fetoplacental unit, increased renal glucose losses, increased 
maternal usage of blood glucose, or a dilutional effect.4-6
CASE REPORT 
A 38-year-old woman (gravida 2, para 0, abortus 1) 
was admitted to the emergency department at 34 weeks of 
pregnancy with nausea and vomiting. The patient had type 1 
diabetes (diagnosed at age seven) treated with insulin glargine 
and lispro. She had a history of nonadherence to insulin 
therapy and one previous intensive care unit admission due to 
DKP at 22 weeks of the same gestation.
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The patient sought care complaining of nausea, vomiting, 
anorexia, and abdominal pain of three days’ duration. She had not 
administered any insulin in the prior seven days. She presented 
drowsy and dehydrated, with a stable blood pressure of 100/70 
millimeters of mercury (mmHg) although tachycardic (140 
beats per minute) and tachypneic (32 breaths per minute). The 
capillary glucose level was 82 milligrams per deciliter (mg/dL) 
(reference range, <200 mg/dL). Laboratory results showed pH 
7.25 (reference range 7.35-7.45), bicarbonate 10 milliequivalent 
per liter (mEq/L) (reference range 21-27 mEq/L), base excess 
-14.9 (reference range -2 to +2), blood glucose 80 mg/dL, and 
urine strongly positive for ketones. She had no signs of infectious 
processes. Point-of-care abdominal ultrasound showed a single 
fetus in cephalic presentation with limb movements, a fetal heart 
rate of 160 beats per minute, and normal amniotic fluid index.
The patient was rehydrated with 5% dextrose and 0.9% 
sodium chloride solution administered at 500 milliliters 
per hour (mL/h) for the first hour, followed by 250 mL/h in 
the succeeding four hours, and then tapered to 125 and 75 
mL/h until resolution of diabetic ketoacidosis. Hydration 
was titrated to ensure a urine output of 0.5 mL/kilogram 
(kg)/h (measured via indwelling catheter). Potassium was 
administered at 20 millimoles (mmol)/L/h until the fourth 
hour of resuscitation. A continuous intravenous (IV) infusion 
of regular insulin was started at 7 units (U)/h.
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What do we already know about this 
clinical entity? 
Diabetic ketoacidosis in pregnancy 
(DKP) develops because of relative 
or absolute insulin deficiency and a 
simultaneous increase in counter-
regulatory hormones.
What makes this presentation of 
disease reportable? 
We report the case and review 
literature regarding DKP in terms of 
diagnosis, treatment, and maternal and 
fetal monitoring. 
What is the major learning point? 
On suspicion of DKP, the physician 
should start treatment after confirming 
the diagnosis, and continuously monitor 
the mother and fetus.
How might this improve emergency 
medicine practice? 
The emergency physician should be 
able to recognize and treat diabetic 
ketoacidosis in pregnant women even if 
they are normoglycemic.
Clinical condition and laboratory data were monitored 
continuously. After 24 hours, laboratory results showed pH 
7.44, bicarbonate 21 mEq/L, and blood glucose levels in 
the normal range. Nevertheless, fetal monitoring showed 
sustained bradycardia after 22 hours in the ED and the 
obstetrics team opted for an emergency cesarean section, 
which was performed uneventfully. The patient was 
discharged 48 hours after cesarean section with a new insulin 
prescription. The neonate was discharged 14 days later.
DISCUSSION 
The Joint British Diabetes Societies Inpatient Care Group 
requires laboratory data to confirm the diagnosis of DKP. The 
diagnostic criteria are as follows: 1) blood ketone level ≥3.0 
mmol/L or urine ketone level >2+; 2) blood glucose level 
>200 mg/dL or known diabetes mellitus; and 3) bicarbonate 
level <15.0 mEq/L and/or venous pH< 7.3.3
The emergency physician must be able to recognize and 
treat DKP even when the patient is normoglycemic. Nausea, 
vomiting, and decreased caloric intake in an otherwise healthy 
pregnant diabetic woman should prompt evaluation to rule out 
ketosis.7 The patient should receive large-bore IV access and 
continuous monitoring of echocardiogram and pulse oximetry.8 
Treatment consists of fluid replacement with isotonic saline at 
10–15 mL/kg/h for the first hour,1 after which the rate should 
be adjusted according to the hemodynamic status of the patient, 
blood pressure, and urine output. The goals are a systolic blood 
pressure ≥90 mmHg and a urine output 0.5 mL/kg/h, monitored 
using an indwelling catheter.3
Management of euglycemic DKP follows the same 
principles as that of regular DKP.3 Insulin should not be 
delayed except for hypokalemia (see below). Therefore, 
in euglycemic ketoacidosis, 5% dextrose is necessary 
from the start of treatment.9 At our facility, we start a 
regular insulin infusion at an initial rate of 0.1 U/kg/h (to 
a maximum of 15 U/h).3 A priming bolus is not required.3 
If metabolic targets are not achieved, the insulin infusion 
is increased by 1 U/h until ketones reach the desired 
level.3 Once DKP is resolved, we administer a first dose 
of subcutaneous rapid-acting insulin and a meal, and 
discontinue the insulin infusion 30–60 minutes later. 3
If the serum potassium is below 3.3 mEq/L, we start 
potassium chloride replacement before starting the insulin 
infusion.3 Patients with a normal urine output and serum 
potassium level <5.5mEq/L should receive potassium chloride 
in order to maintain their potassium level in the range of 
4–5 mEq/L.3 Although whole-body phosphate is decreased, 
replacement is not necessary unless the serum level is <1 
mg/dL or the patient develops cardiopulmonary effects of 
hypophosphatemia.3 Administration of bicarbonate is not 
recommended, as there is no evidence of a beneficial effect and 
it may be harmful to the patient and the fetus.3
Capillary glucose should be monitored hourly to avoid 
hypoglycemia. Blood ketones should be monitored hourly for 
the first six hours; the goal is to decrease rate ketones by at 
least 0.5 mmol/L every hour. Other biochemical parameters, 
such as pH, bicarbonate, and serum potassium, can be 
monitored every two hours. The goal for bicarbonate levels is 
an increase of 3 mEq/L every hour.3
The fetal effects of DKP stem from a combination of 
severe maternal dehydration and acidosis, and may reduce 
uteroplacental perfusion. Maternal electrolyte imbalances may 
result in fetal cardiac arrhythmias.10 The necessary frequency of 
fetal monitoring is unknown, and no definite recommendations 
are currently available.10 Therefore, individualized care with a 
multidisciplinary approach is recommended. The decision to 
deliver should be individualized and based on evaluation of the 
maternal clinical status, laboratory results, fetal gestational age, 
cardiotocography, and ultrasound.11
CONCLUSION
DKP is a medical emergency. The emergency physician 
should be able to recognize and treat it even when the patient 
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is normoglycemic (euglycemic DKP). On suspicion of DKP, 
the diagnosis should be confirmed with laboratory tests. In 
addition to basic measures such as airway maintenance and 
hemodynamic stabilization, treatment consists of large-bore IV 
access, glucose and insulin infusion, correction of electrolytic 
imbalances, and continuous maternal and fetal monitoring. 
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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